PT Hetzer Medical Indonesia Tbk (MEDS.JK)
IDR 50.0
(0.0%)
IDR 50.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 3.15 Billion | -13.02 Billion | 13.48 Billion | 48.68 Billion | -2.6 Billion |
| Net Income | -3.57 Billion | 237.06 Million | 26.63 Billion | 37.96 Billion | 308.41 Million |
| Depreciation & Amortization | 4.15 Billion | 2.96 Billion | 1.72 Billion | 759.52 Million | 205.25 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | - | - | - | - | - |
| Other non-cash items | 10.87 Billion | -10.29 Billion | -11.41 Billion | 11.47 Billion | -2.71 Billion |
| Investing Cash Flow | -6.08 Billion | -17.72 Billion | -27.71 Billion | -7.37 Billion | -863.71 Million |
| Investments in PPE | -6.08 Billion | -17.97 Billion | -27 Billion | -7.37 Billion | -863.71 Million |
| Acquisitions | - | 243.24 Million | 1 Million | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | 243.24 Million | -712.5 Million | - | - |
| Financing Cash Flow | -1.76 Billion | 34.71 Billion | 1.76 Billion | -27.97 Billion | 3.82 Billion |
| Debt repayment | -2.48 Billion | -2.11 Billion | -8.96 Billion | -1.02 Billion | -16.98 Million |
| Dividends payments | - | - | -7.2 Billion | -29 Billion | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 36.82 Billion | - | - | 3.84 Billion |
| Other Financing Activities | 725 Million | 36.82 Billion | -2.1 Billion | -74.44 Million | 3.82 Billion |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Other working capital | - | - | - | - | - |
| Cash at beginning of period | 5.36 Billion | 1.4 Billion | 13.87 Billion | 540.09 Million | - |
| Cash at end of period | 665.56 Million | 5.36 Billion | 1.4 Billion | 13.87 Billion | 540.09 Million |
| Capital Expenditure | -6.08 Billion | -17.97 Billion | -27 Billion | -7.37 Billion | -863.71 Million |
| Effect of forex changes on cash | - | - | - | - | 189.25 Million |
| Net cash flow / Change in cash | -4.69 Billion | 3.96 Billion | -12.46 Billion | 13.33 Billion | 540.09 Million |
| Free Cash Flow | -2.93 Billion | -30.99 Billion | -13.52 Billion | 41.3 Billion | -3.47 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.76 Billion | -927.72 Million | 3.42 Billion | -3.57 Billion | 1.1 Billion | -3.76 Billion |
| Depreciation & Amortization | 1.15 Billion | 1.17 Billion | 1.24 Billion | 4.15 Billion | 506.91 Million | 1.2 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 4.72 Billion | 3.62 Billion | -4.93 Billion | 10.87 Billion | -646.4 Million | 12.11 Billion |
| Investing Cash Flow | -55.52 Million | -132.49 Million | 8.1 Billion | -6.08 Billion | -82.74 Million | -6.22 Billion |
| Investments in PPE | -55.52 Million | -132.49 Million | 8.1 Billion | -6.08 Billion | -82.74 Million | -6.22 Billion |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -674.5 Million | -1.4 Billion | -4.93 Billion | -1.76 Billion | -666.95 Million | -884.92 Million |
| Debt repayment | -1.12 Billion | -1.34 Billion | -2.45 Billion | -2.48 Billion | -986.21 Million | -511.98 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -707.06 Million | -66.08 Million | -4.13 Billion | 725 Million | 4 Million | -693.82 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 656.59 Million | 665.56 Million | 247.15 Million | 5.36 Billion | 1.04 Billion | 1.01 Billion |
| Cash at end of period | 727.42 Million | 656.59 Million | 665.56 Million | 665.56 Million | 247.15 Million | 1.04 Billion |
| Capital Expenditure | -55.52 Million | -132.49 Million | 8.1 Billion | -6.08 Billion | -82.74 Million | -6.22 Billion |
| Effect of forex changes on cash | - | - | 247.15 Million | - | - | - |
| Net cash flow / Change in cash | 70.83 Million | -8.97 Million | 418.41 Million | -4.69 Billion | -797.34 Million | 26.4 Million |
| Free Cash Flow | 745.33 Million | 1.39 Billion | 5.35 Billion | -2.93 Billion | -130.38 Million | 911.33 Million |
SUDTIND-B
8244
SHO
0124
BKD
BUJAW